Citizens maintains Market Outperform rating on Zscaler, $265 price target

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Citizens maintained its Market Outperform rating on Zscaler (ZS) with a $265 price target, implying 22.2% upside from the Oct 8 close. The firm cites strong growth prospects, including 25% revenue growth in FY26 and an $8 billion ARR target by FY31, driven by AI and Zero Trust adoption. Management confidence is bolstered by reaffirmed FY27 guidance and successful new logo acquisitions. This follows similar positive ratings from other analysts like Macquarie and Scotiabank.

Citizens maintained their Market Outperform rating on Zscaler's stock with a price target of $265.00.

The price target implies an upside of 22.2% from the Oct 8 close of $216.81.

Key takeaways from the analyst note

Strong Growth Prospects: Zscaler has demonstrated robust revenue growth, achieving a 25% increase in FY26 and setting a target of $8 billion in annual recurring revenue (ARR) by FY31, which reflects confidence in sustained demand for its cybersecurity solutions amidst increasing enterprise adoption of AI and Zero Trust architectures.

Competitive Positioning and Management Confidence: The company is well-positioned in the market with a comprehensive Zero Trust security platform, as evidenced by its significant daily transaction monitoring and successful new logo acquisitions. The reaffirmation of FY27 guidance by a newly appointed and experienced management team further underscores the firm's strategic execution capabilities and market confidence.

Recent analyst actions on ZS

DateFirmActionRatingPrice target
Oct 7MacquarieMaintainsOutperform$250
Oct 7ScotiabankMaintainsSector Outperform$255
Oct 7RBC CapitalReiteratesOutperform$236
Oct 7TD CowenMaintainsBuy$230
Oct 7StifelMaintainsBuy$235

Across the five most recent analyst notes published on ZS over the past 30 days, price targets range from $230 to $255.

Explore more price target data and ratings for Zscaler on the .

Disclaimer
Select reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice.

Source: TradingView The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.